Skip to main content
Veterinary Medicines

ABCEDYL PA

Authorised
  • PYROGENIUM C5
  • Virola sebifera C3
  • Atropa bella-donna C5
  • ECHINACEA C3
  • Calcium sulfuricum C7
  • ACIDUM SILICICUM C7
  • HEPAR SULFURIS C7

Identifikacija zdravila

Ime zdravila:
ABCEDYL PA
Učinkovina:
Pot uporabe:
  • Peroralna uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    0.14
    gram(s)
    /
    1.00
    millilitre(s)
Farmacevtska oblika:
  • Peroralna raztopina
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QV03AX
Status dovoljenja:
  • Valid
Authorised in:
  • France
Available in:
  • France
Opis ovojnine:

Dodatne informacije

Entitlement type:
Imetnik dovoljenja za promet z zdravilom:
  • Boiron
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boiron
Pristojni organ:
  • National Veterinary Medicines Agency
Številka dovoljenja :
  • FR/V/0687297 7/2001
Datum spremembe statusa dovoljenja:

Dokumenti

Povzetek glavnih značilnosti zdravila

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.
French (PDF)
Objavljeno na: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."